IL-6 induces cardiac fibroblasts to express enhanced fibrosis-related factors in aldosterone-induced cardiac fibrosis in vitro, whereas its inhibition can prevent myocardial fibrosis and cardiac hypertrophy in vivo56. Here, IL6 is linked to cardiac hypertrophy.